Standard BioTools Inc. Financial Ratios — LAB Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-43.16	-19.71	-14.33	-20.15	-13.71	-22.47	-20.39	-19.97	-22.79	-17.99	-19.75	-57.13	-20.93	-29.69	-12.69
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	69.23	70.72	71.62	63.21	59.35	55.95	50.99	54.57	54.83	60.32	53.13	37.83	47.44	49.32	49.86
EBITDA Margin (%)	-33.02	-30.34	-20.84	-23.42	-33.15	-52.9	-39	-27.97	-30.73	-25.42	-39.74	-89.42	-45.01	-77.08	-96.48
Operating Margin (%)	-36.31	-34.53	-24.42	-35.33	-47.2	-70.07	-57.25	-42.64	-44.22	-36.94	-51.66	-104.77	-59.28	-95.6	-109.34
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-77.25
Pretax Margin (%)	-52.03	-36.09	-23.02	-49.55	-47.76	-76.76	-62.59	-54.37	-56.89	-39.16	-48.75	-196.97	-69.78	-99.33	-113.33
Profit Margin (%)	-52.42	-36.35	-23.22	-45.36	-46.48	-72.75	-59.38	-52.24	-55.26	-38.38	-45.36	-194.08	-70.21	-152.61	-87.77
Net Income to Common Margin (%)	-75.52	-36.35	-23.22	-45.36	-46.48	-72.75	-59.38	-52.24	-55.26	-38.38	-45.36	-194.08	-70.21	-203.17	-87.77
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	30.58	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	33.6	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	10	- -	- -	195	195	195	195	172	60	95	112	103	98	31	31
ST Debt	9	- -	- -	- -	- -	- -	- -	- -	2	3	10	6	64	5	5
LT Debt	1	- -	- -	195	195	195	195	172	58	92	102	97	34	26	25
Total Debt/EBITDA	-0.72	- -	- -	-7.17	-5.12	-3.53	-4.91	-5.45	-1.66	-2.72	-2.15	-1.17	-2.05	-0.44	-0.37
Net Debt/EBITDA	0.24	3.69	2.38	-5.93	-4.35	-2.89	-3.45	-2.43	-0.89	0.41	-0.82	0.19	-0.25	2.37	1.46
Total Debt/EBIT	-0.65	- -	- -	-4.75	-3.6	-2.66	-3.35	-3.57	-1.16	-1.87	-1.66	-1	-1.56	-0.35	-0.33
Net Debt/EBIT	0.22	3.25	2.03	-3.93	-3.06	-2.18	-2.35	-1.59	-0.62	0.28	-0.63	0.16	-0.19	1.91	1.29
EBITDA to Interest Expense	-4.56	-25.29	-1,059.64	-5.1	-6.55	-9.49	-6.83	-2.27	-8.42	-9.83	-13.57	-20.22	-10.48	-21.15	-3,166.46
EBITDA-CapEx/Interest Expense	-5.75	-29.08	-1,394.36	-6.49	-8.38	-10.36	-7.1	-2.3	-9.01	-13.39	-17.04	-21.11	-11.1	-23.67	-3,485.81
EBIT to Interest Expense	-5.02	-28.78	-1,241.86	-7.7	-9.32	-12.58	-10.02	-3.47	-12.11	-14.29	-17.65	-23.69	-13.8	-26.24	-3,588.65
Interest Expense	3	1	- -	5	6	6	6	14	4	4	4	4	5	3	- -
Common Equity/Total Assets	-279.58	-211.72	-220.09	-76.1	-98.22	-143.43	-174.06	-184.03	-235.48	-208.37	-267.4	-237.25	-309.74	-193.56	-221.95
Long-Term Debt/Equity (%)	2.14	- -	- -	129.94	169.43	366.22	631.12	238.59	37.85	66.45	107.57	- -	- -	5.49	5.97
Long-Term Debt/Capital (%)	-0.58	- -	- -	-170.41	-115.33	-79.74	-64.03	-44.49	-10.32	-15.9	-16.3	-11.77	-3.81	-2.24	-2.06
Long-Term Debt/Total Assets (%)	1.53	- -	- -	47.96	52.61	63.63	67.94	56.66	21.96	28.45	36.97	24.82	10.63	4.23	4.46
Total Debt/Equity (%)	17.82	- -	- -	129.94	169.43	366.22	631.12	238.59	39.04	68.59	118.03	-126.01	-66.34	6.51	7.27
Total Debt/Capital (%)	-4.79	- -	- -	-170.41	-115.33	-79.74	-64.03	-44.49	-10.64	-16.41	-17.88	-12.47	-10.88	-2.66	-2.51
Total Debt/Total Assets (%)	12.78	- -	- -	47.96	52.61	63.63	67.94	56.66	22.65	29.37	40.57	26.3	30.4	5.01	5.43
Net Debt to Equity	-6	-58.27	-36.57	107.53	144.09	300.39	443.45	106.3	20.94	-10.28	45.03	20.15	-7.98	-35.28	-28.42
Net Debt/Capital (%)	1.52	19.59	12.05	-108.99	-83.65	-57.2	-37.79	-15.9	-5.5	2.2	-6.53	1.81	-1.24	12.6	8.93
EBITDA	-14	-16	-15	-27	-38	-55	-40	-32	-36	-35	-52	-88	-48	-70	-82
EBITDA-CapEx	-18	-18	-20	-35	-49	-60	-41	-32	-39	-48	-65	-91	-51	-78	-91
Operating Income (Loss)	-16	-18	-17	-41	-54	-73	-58	-48	-52	-51	-67	-103	-63	-87	-93

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	2.65	6.9	4.7	3.92	3.16	2.01	1.89	2.54	1.79	1.26	0.57	3.82	1.05	4.44	1.73
Current Ratio	3.47	8.73	5.83	5.31	4.79	3.28	2.83	3.38	2.93	2.17	1.45	4.81	1.45	5.7	4.19
Quick Ratio	3.11	8.01	5.29	4.69	4	2.51	2.34	2.98	2.36	1.73	0.94	4.21	1.23	4.67	1.86
CFO/Avg Current Liab	-0.91	-1.1	-0.11	-0.96	-1.17	-1.31	-0.77	-0.71	-1	-0.35	-0.85	-1.92	-0.57	-1.64	-0.85
Common Equity/Total Assets	-279.58	-211.72	-220.09	-76.1	-98.22	-143.43	-174.06	-184.03	-235.48	-208.37	-267.4	-237.25	-309.74	-193.56	-221.95
Long-Term Debt/Equity (%)	2.14	- -	- -	129.94	169.43	366.22	631.12	238.59	37.85	66.45	107.57	- -	- -	5.49	5.97
Long-Term Debt/Capital (%)	-0.58	- -	- -	-170.41	-115.33	-79.74	-64.03	-44.49	-10.32	-15.9	-16.3	-11.77	-3.81	-2.24	-2.06
Long-Term Debt/Total Assets (%)	1.53	- -	- -	47.96	52.61	63.63	67.94	56.66	21.96	28.45	36.97	24.82	10.63	4.23	4.46
Total Debt/Equity (%)	17.82	- -	- -	129.94	169.43	366.22	631.12	238.59	39.04	68.59	118.03	-126.01	-66.34	6.51	7.27
Total Debt/Capital (%)	-4.79	- -	- -	-170.41	-115.33	-79.74	-64.03	-44.49	-10.64	-16.41	-17.88	-12.47	-10.88	-2.66	-2.51
Total Debt/Total Assets (%)	12.78	- -	- -	47.96	52.61	63.63	67.94	56.66	22.65	29.37	40.57	26.3	30.4	5.01	5.43
CFO/Total Liabilities	-78.21	-133.67	-7.76	-8.8	-13.61	-15.46	-9.4	-10.88	-31.66	-8.3	-24.39	-18.94	-9.19	-102.01	-51.82
CFO/CapEx	-4.77	-7.33	-0.34	-3.06	-3.26	-7.73	-14.91	-67.74	-13.91	-1.21	-3.32	-23.36	-15.29	-17.17	-8.95
Altman's Z-Score	3.02	12.45	26.47	0.69	-1.88	-5.3	-6.12	-4.35	-6.37	-3.73	-6.86	-4.82	-6.48	-0.51	-0.73

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	4.94	4.72	6.07	7.07	4.8	5.21	6.87	7.13	6.58	6.22	5.97	5.5	5.76	5.29	6.06
Days Sales Outstanding	73.88	77.25	60.13	51.61	76.11	70.01	53.1	51.21	55.46	58.66	61.14	66.33	63.4	68.98	60.25
Inventory Turnover	2.43	2.33	2.64	3.55	2.75	2.42	2.84	3.65	3.94	3.27	3.02	2.88	2.66	2.23	2.1
Days Inventory Outstanding	150.29	156.47	138.36	102.81	132.74	150.88	128.6	99.9	92.65	111.77	120.8	126.76	137.16	163.32	173.7
Accounts Payable Turnover	3.98	5.03	6.13	9.87	8.09	9.58	10.99	11.95	11.73	8.44	6.29	6.65	6.41	6.49	8.04
Accounts Payable Turnover Days	91.65	72.51	59.52	36.98	45.14	38.09	33.22	30.54	31.11	43.27	58.03	54.91	56.96	56.26	45.41
Cash Conversion Cycle	132.53	161.21	138.97	117.44	163.7	182.8	148.48	120.58	117	127.17	123.91	138.19	143.6	176.04	188.55
Inventory to Cash Days	-76.41	-79.22	-78.23	-51.2	-56.62	-80.87	-75.5	-48.69	-37.18	-53.11	-59.66	-60.43	-73.77	-94.33	-113.45
Inventories	6	7	8	16	18	20	15	13	14	20	21	21	21	21	20
Raw Materials	2	3	3	5	7	9	8	6	6	8	9	17	12	13	9
Work In Process	1	1	2	4	2	2	1	1	1	1	1	1	- -	- -	- -
Finished Goods	3	3	4	8	9	9	7	6	7	10	11	15	8	7	11
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	235	317	975	937	310	211	194	342	232	432	297	92	175	617	488
- Cash & Cash Equivalents	14	59	35	34	29	35	58	95	22	69	28	81	52	167	121
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	10	- -	- -	195	195	195	195	172	60	95	112	103	98	31	31
Enterprise Value	192	237	891	1,017	410	347	326	418	234	459	380	28	158	355	332
Total Capital	-212	-241	-257	-115	-169	-244	-305	-387	-564	-581	-624	-823	-902	-1,155	-1,229
Total Debt/Capital (%)	-4.79	- -	- -	-170.41	-115.33	-79.74	-64.03	-44.49	-10.64	-16.41	-17.88	-12.47	-10.88	-2.66	-2.51
Total Debt / EV	0.05	- -	- -	0.19	0.47	0.56	0.6	0.41	0.26	0.21	0.29	3.6	0.62	0.09	0.09
EV/Sales	4.47	4.52	12.52	8.73	3.57	3.32	3.2	3.7	1.99	3.32	2.91	0.29	1.49	3.9	3.89
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	286.57	- -	- -	- -	- -	- -	- -	573.45	- -	- -	- -	- -	- -
Diluted Market Cap	235	317	975	937	310	211	194	342	232	432	297	92	175	617	488
Diluted Enterprise Value	231	258	940	1,098	476	371	331	418	271	459	380	113	221	481	398
EV per Share	10.73	10.7	34.97	36.62	14.28	11.95	9.9	10.55	3.5	6.37	5.02	0.36	2	1.01	0.87
TTM Sales	43	52	71	116	115	104	102	113	117	138	131	98	106	91	85
TTM EBITDA	-14	-16	-15	-27	-38	-55	-40	-32	-36	-35	-52	-88	-48	-70	-82
TTM Operating Income	-16	-18	-17	-41	-54	-73	-58	-48	-52	-51	-67	-103	-63	-87	-93
TTM Cash Flow to Firm	-14	-17	-2	-18	-29	-34	-19	-12	-31	-12	-41	-85	-39	-140	-74
TTM Free Cash Flow to Firm	-11	-14	3	-10	-18	-29	-17	-11	-29	1	-27	-81	-36	-132	-66

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-16.94	-20.99	315.13	-61.54	-12.89	-6.2	-8.64	-13.77	-7.11	-160.1	-9.65	-1.07	-4.32	-4.57	-7.4
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	192	237	891	1,017	410	347	326	418	234	459	380	28	158	355	332
Low Price	11.64	12.28	14	21.71	7.2	4.31	2.52	4.65	2.12	1.17	3.59	0.92	1.16	1.21	0.92
EV/Sales	4.47	4.52	12.52	8.73	3.57	3.32	3.2	3.7	1.99	3.32	2.91	0.29	1.49	3.9	3.89
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-8.1	-17.14	-32.31	-17.34	-12.9	-3.07	-2.82	-4.56	-8.89	-6.9	-7.07	-0.89	-2.31	-4.13	-6.58
Price/Earnings High	-11.14	-20.05	-61.04	-26	-24.98	-4.22	-4.73	-6.1	-15.36	-16.92	-9.61	-1.74	-3.35	-5.8	-10.9
Price/Earnings Low	-6.42	-14.29	-21.58	-11.41	-3.88	-1.65	-1.37	-3.12	-2.19	-1.59	-4.59	-0.38	-1.23	-2.31	-4.69
Price/Book Value	-1.06	-1.32	-3.79	-3.02	-0.85	-0.48	-0.39	-0.61	-0.37	-0.64	-0.4	-0.1	-0.17	-0.52	-0.39
Price/Book Value Average	-1.18	-1.35	-2.08	-2.95	-1.89	-0.53	-0.34	-0.48	-0.92	-0.54	-0.57	-0.18	-0.17	-0.64	-0.39
Price/Book Value High	-1.63	-1.58	-3.92	-4.43	-3.66	-0.73	-0.57	-0.64	-1.6	-1.33	-0.77	-0.36	-0.25	-0.9	-0.65
Price/Book Value Low	-0.94	-1.13	-1.39	-1.94	-0.57	-0.28	-0.17	-0.33	-0.23	-0.12	-0.37	-0.08	-0.09	-0.36	-0.28
Price/Tangible Book Value	4.13	3.15	10.12	-16.76	-3.52	-1.54	-1.32	-3.64	624.71	-44.39	-7.25	-0.46	-0.68	1.86	1.15
Price/Tangible Book Value Average	4.61	3.24	5.54	-16.39	-7.81	-1.7	-1.16	-2.87	1,549.12	-37.59	-10.22	-0.84	-0.67	2.3	1.16
Price/Tangible Book Value High	6.34	3.79	10.46	-24.57	-15.11	-2.33	-1.95	-3.84	2,674.75	-92.12	-13.89	-1.65	-0.98	3.23	1.92
Price/Tangible Book Value Low	3.65	2.7	3.7	-10.79	-2.35	-0.91	-0.56	-1.97	380.57	-8.66	-6.64	-0.36	-0.36	1.29	0.83
Price/Sales	5.48	6.05	13.7	8.04	2.71	2.02	1.91	3.03	1.98	3.13	2.28	0.94	1.65	6.78	5.72
Price/Sales Average	6.12	6.23	7.5	7.87	5.99	2.23	1.68	2.38	4.92	2.65	3.21	1.73	1.62	8.39	5.77
Price/Sales High	8.41	7.29	14.17	11.79	11.61	3.07	2.81	3.19	8.49	6.49	4.36	3.38	2.35	11.78	9.57
Price/Sales Low	4.85	5.19	5.01	5.18	1.8	1.2	0.82	1.63	1.21	0.61	2.08	0.74	0.86	4.69	4.11
Price/Cash Flow	-13.39	-18.12	-613.03	-41.4	-8.94	-5.4	-8.06	-13.56	-6.6	-28.04	-6.74	-1.03	-4.04	-4.3	-6.57
Price/Cash Flow Average	-14.94	-18.65	-335.6	-40.5	-19.8	-5.96	-7.1	-10.68	-16.37	-23.74	-9.5	-1.89	-3.98	-5.32	-6.63
Price/Cash Flow High	-20.55	-21.82	-634.01	-60.71	-38.34	-8.19	-11.89	-14.29	-28.26	-58.18	-12.92	-3.71	-5.78	-7.47	-10.99
Price/Cash Flow Low	-11.84	-15.55	-224.2	-26.65	-5.95	-3.19	-3.45	-7.32	-4.02	-5.47	-6.17	-0.81	-2.12	-2.97	-4.72
Price/Free Cash Flow Average	-18.91	-21.6	172.52	-60.19	-28.56	-6.84	-7.61	-10.84	-17.63	-135.57	-13.6	-1.98	-4.26	-5.65	-7.46
Price/Free Cash Flow High	-26	-25.27	325.92	-90.24	-55.3	-9.41	-12.75	-14.5	-30.45	-332.2	-18.48	-3.87	-6.18	-7.94	-12.37
Price/Free Cash Flow Low	-14.98	-18.01	115.25	-39.61	-8.58	-3.67	-3.7	-7.43	-4.33	-31.22	-8.83	-0.84	-2.27	-3.16	-5.32
EV/Sales Average	6.04	5.11	7.01	9.26	7.44	3.76	3.02	3.06	5.24	2.84	3.84	1.94	2.06	6.9	4.72
EV/Sales High	8.33	6.17	13.68	13.18	13.05	4.6	4.16	3.87	8.81	6.69	5	3.6	2.79	10.29	8.52
EV/Sales Low	4.77	4.07	4.52	6.57	3.25	2.73	2.16	2.31	1.53	0.8	2.72	0.95	1.3	3.19	3.06
EV/EBITDA Average	-18.28	-16.83	-33.62	-39.51	-22.44	-7.11	-7.75	-10.95	-17.06	-11.19	-9.67	-2.17	-4.57	-8.95	-4.89
EV/EBITDA High	-25.23	-20.32	-65.62	-56.28	-39.37	-8.7	-10.66	-13.82	-28.68	-26.31	-12.57	-4.03	-6.2	-13.34	-8.83
EV/EBITDA Low	-14.43	-13.42	-21.67	-28.03	-9.79	-5.16	-5.54	-8.26	-4.99	-3.17	-6.85	-1.07	-2.89	-4.14	-3.17
EV/EBIT Average	-16.62	-14.79	-28.68	-26.2	-15.76	-5.37	-5.28	-7.18	-11.86	-7.7	-7.44	-1.86	-3.47	-7.22	-4.32
EV/EBIT High	-22.94	-17.86	-55.99	-37.32	-27.65	-6.56	-7.26	-9.07	-19.93	-18.1	-9.67	-3.44	-4.71	-10.76	-7.79
EV/EBIT Low	-13.13	-11.8	-18.49	-18.58	-6.88	-3.89	-3.77	-5.42	-3.47	-2.18	-5.27	-0.91	-2.19	-3.34	-2.8
Last Price	13.16	14.31	38.28	33.73	10.81	7.28	5.89	8.62	3.48	6	3.92	1.17	2.21	1.75	1.28
High Price	20.2	17.23	39.59	49.46	46.38	11.05	8.69	9.08	14.9	12.45	7.51	4.23	3.16	3.04	2.14
Enterprise Value Average	259	267	499	1,078	853	393	308	346	615	393	502	190	219	628	403
Enterprise Value High	357	323	973	1,535	1,497	480	424	437	1,033	924	652	353	297	936	727
Enterprise Value Low	204	213	321	765	372	285	220	261	180	111	355	93	138	291	261

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	20	25	26	28	29	29	39	49	70	75	77	79	80	378	386
Diluted Weighted Avg Shares	18	22	25	28	29	29	33	40	67	72	76	78	79	353	382
Basic Weighted Avg Shares	18	22	25	28	29	29	33	40	67	72	76	78	79	353	382
Revenue per Share	2.4	2.36	2.79	4.19	4	3.6	3.09	2.85	1.76	1.92	1.72	1.25	1.34	0.26	0.22
EBITDA per Share	-0.79	-0.72	-0.58	-0.98	-1.32	-1.9	-1.21	-0.8	-0.54	-0.49	-0.68	-1.12	-0.6	-0.2	-0.22
Operating Income per Share	-0.87	-0.82	-0.68	-1.48	-1.89	-2.52	-1.77	-1.21	-0.78	-0.71	-0.89	-1.31	-0.8	-0.25	-0.24
Basic EPS, GAAP	-1.81	-0.86	-0.65	-1.9	-1.86	-2.62	-1.84	-1.49	-0.97	-0.74	-0.78	-2.43	-0.94	-0.52	-0.2
Basic EPS from Cont Ops	-1.26	-0.86	-0.65	-1.9	-1.86	-2.62	-1.84	-1.49	-0.97	-0.74	-0.78	-2.43	-0.94	-0.26	-0.15
Diluted EPS, GAAP	-1.81	-0.86	-0.65	-1.9	-1.86	-2.62	-1.84	-1.49	-0.97	-0.74	-0.78	-2.43	-0.94	-0.52	-0.2
Diluted EPS from Cont Ops	-1.26	-0.86	-0.65	-1.9	-1.86	-2.62	-1.84	-1.49	-0.97	-0.74	-0.78	-2.43	-0.94	-0.26	-0.15
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.98	-0.79	-0.06	-0.81	-1.21	-1.35	-0.73	-0.64	-0.53	-0.21	-0.58	-1.14	-0.55	-0.41	-0.19
Free Cash Flow per Basic Share	-1.19	-0.9	-0.25	-1.08	-1.58	-1.52	-0.78	-0.64	-0.57	-0.39	-0.76	-1.19	-0.58	-0.43	-0.22
Cash & Equivalents per Share	3	3.61	3.31	4.15	3.31	2.05	1.91	2.41	0.88	0.95	0.38	2.12	1.45	0.83	0.49
Book Value per Share	-12.43	-10.88	-10.1	-11.17	-12.66	-15.15	-15.17	-14.09	-9.34	-9.39	-9.71	-11.83	-12.64	-3.36	-3.3
Tangible Book Value per Share	3.19	4.55	3.78	-2.01	-3.07	-4.74	-4.47	-2.37	0.01	-0.14	-0.54	-2.56	-3.23	0.94	1.11

Standard BioTools Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)